Navigation Links
Thomson Reuters Launches New Developments to Support Synthetic Chemists
Date:8/13/2009

PHILADELPHIA and LONDON, Aug. 13 /PRNewswire/ -- Thomson Reuters today announced the newest release of Prous Science Integrity(R) developed in response to demand from synthetic chemists in pharmaceutical and fine chemical companies.

The redesigned Organic Synthesis Knowledge Area within Prous Science Integrity allows researchers to directly retrieve intermediates and reagents, as well as synthesis schemes, to pinpoint key characteristics of synthesis route components in seconds. New visualizations and filtering methods plus incorporation of the latest industry standard chemical taxonomony (InChIs) enable new research approaches that save time and provide insights. All these new capabilities can be applied to the foundation of 19,000 schemes of synthesis and 85,000+ structure-searchable intermediates that make Prous Science Integrity a powerful resource to synthetic chemists in the pharmaceuticals and fine chemicals industries.

Pharmaceutical synthetic chemists will value this improved support to easily identify competitor activity, evaluate newly designed synthetic routes and locate suppliers of selected intermediates, while chemists at fine chemicals companies will be able to identify what new drugs are in development and at what phase, giving them the opportunity to promote their existing chemicals, develop new intermediates or highlight alternative steps in a synthesis scheme.

"Prous Science Integrity is being developed to encompass the new paradigm of translational research," said Josep Prous, Jr., Ph.D., Vice President and Chief Scientific Officer at Thomson Reuters. "The features found in this most recent version support the quality data and innovative functionality that customers have come to expect from Thomson Reuters."

Thomson Reuters will be attending the 238(th) American Chemical Society's National Meeting and Exposition, August 16-20, 2009 in Washington, DC and ChemOutsourcing, September 14-16, 2009 in Long Branch, NJ. Researchers are encouraged to come and receive a demonstration of the latest changes to Prous Science Integrity.

The upgrade is the first of several planned phases over the next year that will increase the depth and breadth of information and add new features, while continuing to provide the highest quality content.

Prous Science Integrity seamlessly integrates biological, chemical and pharmacological information on more than 300,000 compounds with demonstrated biological activity, plus tens of thousands of synthesis intermediates and over 125,000 patent family records. Updated daily, this unique database is designed to support the drug discovery and development activities for thousands of pharmacologists and medicinal chemists as well as other scientific researchers. Find out more about Prous Science Integrity here.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Thomson Reuters Invites You to the First Latin American Forum Covering the Pharmaceutical Industry
2. Thomson Reuters Research Identifies Top U.S. Health Systems
3. Price Chopper Supermarkets Deploy Micromedex Solutions From Thomson Reuters as Key Component of Its Patient-Centered Care Initiatives
4. Patients With Bipolar Disorder at Increased Risk for Wide Range of Health Problems, Thomson Reuters Study Finds
5. Clear Choice Health Plans Selects Thomson Reuters to Deliver Healthcare Cost Information to Members - and Exceed State Transparency Requirements
6. CDCs National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms
7. Taiwans Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development
8. Thomson Reuters Study Finds Baby Boomers and Generation X Face Healthcare Cost Hurdles
9. Accurays Euan Thomson Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Recipient in Northern California
10. Thomson Reuters Partners with Research4Life to Bring Scientific Research Information Resources to Developing Countries Around the World
11. Thomson Reuters Offers Average Wholesale Pricing Information for Workers Compensation Drug Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology: